The role of cytokines in pancreatic cancer.
Schmielau
J
J
Medizinische Universitätsklinik, Knappschaftskrankenhaus, Ruhr-Universität Bochum, Germany.
Kalthoff
H
H
Roeder
C
C
Schmiegel
W
W
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D016207:Cytokines / Q000378:metabolism / Q000502:physiology*; D066246:ErbB Receptors / Q000502:physiology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000502:physiology; D006801:Humans; D007167:Immunotherapy; D010190:Pancreatic Neoplasms / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D010982:Platelet-Derived Growth Factor / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism; D015398:Signal Transduction; D015291:Transforming Growth Factors / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D016207:Cytokines; D010982:Platelet-Derived Growth Factor; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D015291:Transforming Growth Factors; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D066246:ErbB Receptors